Everleap Expands Fertility Care in Greater Houston Metropolitan Area with New Clinic in The Woodlands, Texas

Full-service Clinic Brings Advanced Fertility Care Closer to Patients in Northern Houston Suburbs

THE WOODLANDS, Texas--(BUSINESS WIRE)--Everleap Fertility, a U.S. leader in fertility care formerly known as RMA Houston, and part of IVI Institute, the global leader in reproductive medicine, announced the opening of Everleap Fertility The Woodlands, a new clinic that provides greater access to care for those living and working in the Northern Houston suburban community. The full-service facility, located at 9303 New Trails Drive, Suite 100, is Everleap Fertility’s second location in Texas.

“The Woodlands is a natural extension of our existing Houston practice, allowing us to bring advanced fertility care closer to patients in the northern Houston suburbs who may find it difficult or inconvenient to travel into the city for appointments,” said Dr. Caroline Juneau, Reproductive Endocrinologist and Infertility Specialist practicing at The Woodlands clinic.

Everleap Fertility offers a wide range of fertility treatments including IVF, intrauterine insemination (IUI), preimplantation genetic testing (PGT), egg freezing, and donor egg, sperm, and gestational surrogacy services for every stage of patients’ fertility journeys. It also offers family planning resources and options for LGBTQ+ individuals and fertility preservation treatments for those with autoimmune diseases or cancer diagnoses.

Based on U.S. findings from the IVI Institute Fertility Barometer, becoming a mother is an important life goal for most women—more than half of those surveyed describe it as one of their highest personal priorities. However, the study also shows that infertility is far more common than many people assume. One in five US women aged 19–49 report having experienced infertility at some point in their lives—and for many women, the decision to pursue fertility treatment is complex. Among the perceived barriers to treatment, nearly 38% cited waiting lists and distance to clinics.

“We know that distance from a clinic is a key factor in whether people seek treatment, and expanding our presence in the Greater Houston area will make it easier for the one in five Texans facing infertility to access the care they need and begin their family-building journey,” added Dr. Nola Herlihy, Medical Director, Physician Partner, and Reproductive Endocrinology and Infertility Specialist at Everleap Fertility. “Our team is excited to bring the same high standard of care, excellent patient experience, and industry-leading outcomes that Everleap Fertility is known for to this growing community.”

Everleap Fertility – The Woodlands is open and scheduling new patient visits. Appointments can be made by calling the office at 281-747-6595 or by visiting https://www.everleapfertility.com/request-an-appointment

About Everleap Fertility
Built on the legacy of RMA, Boston IVF, Conceptions, and six other leading North American fertility practices, Everleap Fertility brings together physicians and embryologists across 65+ locations in the U.S., including 25 IVF laboratories focused on the next leap forward in reproductive medicine. Together, we have helped hundreds of thousands of patients build families for more than 40 years. As part of IVI Institute, Everleap Fertility contributes to a global community working together to advance the field and bring progress in reproductive medicine into patient care. For more information, visit everleapfertility.com.

About IVI Institute
IVI Institute is the global leader in reproductive medicine, bringing together world-class fertility clinics and expertise to advance the future of fertility care around the world. With 100+ babies born every day across more than 200 locations in 15 countries – including IVI Fertility, Everleap Fertility, LIVIO, Create Fertility, and TRIO clinics, among other brands – IVI Institute accelerates innovation, expands knowledge, and improves outcomes for patients around the world through groundbreaking research, collaboration, and rigorous clinical standards. Learn more at www.iviinstitute.com.